CDTTW

NASD CDT Equity Inc. - Warrant
Nov 5, 2026 · 12:56 PM ET DELAYED Market Open

$0.0074 ↑ +0.0040 (+117.65%) Trading Up from the previous close of $0.0034

YTD change
+34.55%
vs 20-day SMA
-18.48%
vs 200-day SMA
-29.01%

Price ranges

Previous day
$0.0034 $0.0034
open $0.0034 close $0.0034
+$0.0000 (+0.00%)
Today
$0.0000 $0.0000
open $0.0074 now $0.0074
+$0.0000 (+0.00%)
Past week
$0.0031 $0.0075
from $0.0072 now $0.0074
+$0.0002 (+2.78%)
Past month
$0.0020 $0.0129
from $0.0129 now $0.0074
-$0.0055 (-42.64%)
This year
$0.0020 $0.0200
from $0.0055 now $0.0074
+$0.0019 (+34.55%)

Price & Performance

-0.01 (-72.58%) / 6M

$0.0013$0.0079$0.0146$0.0212May 6Aug 6Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 95.4% away from all-time highs of $0.1600
  • CDTTW is up 35% since the beginning of the year
  • CDTTW is down 43% over the past 12 months
  • CDTTW is down 43% over the past 1 month

CDTTW reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -72.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap N/A

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $930.67 -4.39%
IQV IQVIA Holdings Inc $263.79 +0.46%
CRL Charles River Laboratories International, Inc. $326.29 -7.27%
ICLR ICON Plc $203.11 -0.32%
IT Gartner, Inc. $207.19 +1.45%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.